The HOX gene network as a potential target for cancer therapy

Current Cancer Therapy Reviews

Volumn 3, Issue 1, 2007, Pages 17-24

  Cantile, Monica ^a   Schiavo, Giulia ^b   Terracciano, Luigi ^b   Cillo, Clemente ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Antisense oligonucleotides; Breast cancer; Kidney cancer; RNA interference (RNAi); Tritorax genes

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CYCLIC AMP; CYTOKERATIN; FOMIVIRSEN; HOX PROTEIN; ONCOPROTEIN; REGULATOR PROTEIN; SMALL INTERFERING RNA; TAMOXIFEN; UROKINASE; VASCULOTROPIN;

ADJUVANT THERAPY; ANTINEOPLASTIC ACTIVITY; BLADDER CANCER; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER RECURRENCE; CARCINOGENESIS; CELL NUCLEUS; CELLULAR DISTRIBUTION; COLON CANCER; DRUG TARGETING; EMBRYO DEVELOPMENT; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; KIDNEY CANCER; LUNG CANCER; MONOTHERAPY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SKIN CANCER;

EID: 34047122624     PISSN: 15733947     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339407780126593     Document Type: Review

References (75)

1. Bulger M, Groudine M. Looping versus linking: toward a model for long-distance gene activation. Genes Dev 1999; 13: 2465-77.
2. Spitz F, Gonzalez F, Duboule D. A global control region defines a chromosomal regulatory landscape containing the HoxD cluster. Cell 2003; 113: 405-417.
3. Ellies DL, Krumlauf R. Bone formation: The nuclear matrix reloaded. Cell 2006; 125: 840-2.
4. Pennisi E. Genes commute to factories before they start work. Science 2006; 312: 1304.
5. Ringrose L, Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 2004; 38: 413-43.
6. Bantignies F, Cavalli G. Cellular memory and dynamic regulation of polycomb group proteins. Curr Opin Cell Biol 2006; 18: 275-83.
7. Lewis EB. A gene complex controlling segmentation in Drosophila. Nature 1978; 276: 565-70.
8. Scott MP. Vertebrate homeobox gene nomenclature. Cell 1992; 71: 551-3.
9. Graham A, Papalopulu N, Krumlauf R. The murine and Drosophila homeobox gene complexes have common features of organization and expression. Cell 1989; 57: 367-378.
10. Dekker EJ, Pannese M, Houtzager E, Timmermans A, Boncinelli E, Durston A. Xenopus Hox-2 genes are expressed sequentially after the onset of gastrulation and are differentially inducible by retinoic acid. Dev Suppl 1992; 195-202.
11. Lumsden A, Krumlauf R. Patterning the vertebrate neuraxis. Science 1996; 274: 1109-1115.
12. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
13. Cillo C. HOX Genes in Human Cancers. Invasion and Metastasis 1994-95; 14: 38-49.
14. Garcia-Bellido A. Genetic control of wing disc development in Drosophila. Volume 29, CIBA Foundation Symposium Edition: Elsevier, Amsterdam 1975.
15. Scott MP. Hox genes, arms and the man. Nature 1997; 15: 117-118.
16. Castelli-Gair Hombria J, Lovergrove B. Beypnd homeosis- HOX function in morphogenesis and organogenesis. Differentiation 2003; 71: 461-476.
17. Cillo C, Faiella A, Cantile M, Boncinelli E. Homeobox genes and cancer. Exp Cell Res 1999; 248: 1-9.
18. Cillo C, Cantile M, Faiella A, Boncinelli E. Homeobox genes in normal and malignant cells. J Cell Physiol 2001; 188: 161-169.
19. Chen H, Sukumar S. HOX genes: emerging stars in cancer. Cancer Biol Ther 2003; 2: 524-5.
20. Raman V, Martensen SA, Reisman D, et al. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 2000; 405: 974-978.
21. Cantile M, Pettinato G, Procino A, Feliciello I, Cindolo L, Cillo C. In vivo expression of the whole HOX gene network in human breast cancer. Eur J Cancer 2003; 39: 257-64.
22. Ma XJ, Wang Z, Ryan PD, et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004; 5: 607-16.
23. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002; 20: 3628-36.
24. Dalton LW, Pinder SE, Elston CE, et al. Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement. Mod Pathol 2000; 13: 730-5.
25. Bonner RF, Emmert-Buck M, Cole K, et al. Laser capture microdissection: molecular analysis of tissue. Science 1997; 278: 1481-1483.
26. Cantile M, Cindolo L, Napodano G, Altieri V, Cillo C. Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas. Oncogene 2003; 22: 6462-8.
27. Simon R, Struckmann K, Schraml P, et al. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene 2002; 21: 2476-83.
28. Yoon SJ, LeBlanc-Straceski J, Ward D, Krauter K, Kucherlapati R. Organization of the human keratin type II gene cluster at 12q13. Genomics 1994; 24: 502-8.
29. Jave-Suarez LF, Winter H, Langbein L, Rogers MA, Schweizer J. HOXC13 is involved in the regulation of human hair keratin gene expression. J Biol Chem 2002; 277: 3718-26.
30. Lussier M, Filion M, Compton JG, Nadeau JH, Lapointe L, Royal A. The mouse keratin 19-encoding gene: sequence, structure and chromosomal assign. Gene 1990; 95: 203-13.
31. Moll. I, Achtstatter T, Becht E, Balcarova-Stander J, Ittensohn M, Franke WW. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines. Am J Pathol 1988; 132: 123-44.
32. Hostikka SL, Capecchi MR. The mouse Hoxc11 gene: genomic structure and expression pattern. Mech Dev 1998; 70: 133-45.
33. Singh D, Febbo PG, Ross K, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002; 1: 203-9.
34. Cantile M, Kisslinger A, Cindolo L, et al. cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers. J Cell Physiol 2005; 205: 202-10.
35. Bang YJ, Pirnia F, Fang WG, et al. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci U S A 1994; 91: 5330-5334.
36. Lin DL, Whitney MC, Yao Z, Keller ET. Interleukin-6 induces androgen responsiveness in prostate cancer cells through upregulation of androgen receptor expression. Clin Cancer Res 2001; 7: 1773-1781.
37. Zakany J, Kmita M, Duboule D. A dual role for Hox genes in limb anterior-posterior asymmetry. Science 2004; 304: 1669-1672.
38. Podlasek CA, Duboule D, Bushman W. Male accessory sex organ morphogenesis is altered by loss of function of Hoxd-13. Dev Dyn 1997; 208: 454-465.
39. Petrovics G, Zhang W, Makarem M, et al. Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 2004; 23: 605-611.
40. Kleiderlein JJ, Nisson PE, Jessee J, et al. CCG repeats in cDNAs from human brain. Hum Genet 1998; 103: 666-673.
41. Niwa N, Hiromi Y, Okabe M. A conserved developmental program for sensory organ formation in Drosophila melanogaster. Nat Gen 2004; 36: 293-297.
42. Sabarinadh C, Subramanian S, Tripathi A, Mishra RK. Extreme conservation of noncoding DNA near HoxD complex of vertebrates. BMC Genomics 2004; 5: 75.
43. Casolari JM, Brown CR, Komili S, West J, Hieronymus H, Silver PA. Genome-wide localization of the nuclear transport machinery couples transcriptional status and nuclear organization. Cell 2004; 117: 427-39.
44. Misteli T. Spatial positioning; a new dimension in genome function. Cell 2004; 119: 153-6.
45. Lee JE, Hollenberg SM, Snider L, Turner DL, Lipnick N, Weintraub H. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 1995; 268: 836-844.
46. Cindolo L, Franco R, Cantile M, Botti G, Gallo A, Cillo. C. NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension? Eur Urol 2006; PHID 17126478.
47. Saxèn L. Organogenesis of the kidney. Cambridge Univ. Press, Cambridge, UK 1987; 1-173.
48. Potter EL. Normal and abnormal development of the kidney. Year Book Medical publishers Inc, Chicago 1972.
49. Patterson LT, Pembaur M, Potter SS. Hoxa11 and Hoxd11 regulate branching morphogenesis of ureteric bud in the developing kidney. Development 2001; 128: 2153-2161.
50. Kreidberg JA, Sariola H, Loring JM, et al. Wtl is required for early kidney development. Cell 1993; 74: 679-691.
51. Torres M, Gomez-Pardo E, Dressler GR, Gruss P. Pax2 controls multiple steps of urogenital development. Development 1995; 121: 4057-4065.
52. Nishinakamura R, Matsumoto Y, Nakao K, et al. Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development Development 2001; 128: 3105-3115.
53. Kume T, Deng K, Hogan BL. Murine forkhead/winged helix genes Foxc1 (Mf1) and Foxc2 (Mfh1) are required for the early organo-genesis of the kidney and urinary tract. Development 2000; 127: 1387-1395.
54. Xu PX, Adams J, Peters H, Brown MC, Heaney S, Maas R. Eyal-deficient mice lack ears and kidneys and show abnormal apoptosis oforgan primordia. Nat Genet 1999; 23: 113-117.
55. Davies JA, Fisher CE. Genes and proteins in renal development. Exp Nephrol 2002; 10: 102-113.
56. Pichel JG, Shen L, Sheng HZ, et al. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 1996; 382: 73-76.
57. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994; 367: 380-383.
58. Cacalano G, Farinas I, Wang LC, et al. GFRalphal is an essencial receptor component for GDNF in the developing nervous system and kidney. Neuron 1998; 2: 53-62.
59. Stark K, Vaino S, Vassileva G, McMahon AP. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 1994; 372: 679-683.
60. Wellik DM, Hawkes PJ, Capecchi MR, Hox11 paralogous genes are essencial for metanephric kidney induction. Genes Dev 2002; 16: 1423-1432.
61. Warot X, Fromental-Ramain C, Fraulob V, Chambon P, Dollè P. Gene dosage-dependent effects of the Hox a13 and Hox d13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development 1997; 124: 4781-4791.
62. Chariot A, van Lint C, Chapelier M, Gielen J, Merville MP, Bours V. CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein. Oncogene 1999; 18: 4007-14.
63. Petruk S, Sedkov Y, Smith S, et al. Trithorax and dCBP acting in a complex to maintain expression of a homeotic gene. Science 2001; 294: 1331-4.
64. Ernst P, Wang J, Huang M, Goodman RH, Korsmeyer SJ. MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein. Mol Cell Biol 2001; 21: 2249-58.
65. Shen WF, Krishnan K, Lawrence HJ, Largman C. The HOX homeodomain proteins block CBP histone acetyltransferase activity. Mol Cell Biol 2001; 21: 7509-22.
66. Eklund EA. The role of HOX genes in myeloid leukemogenesis. Curr Opin Hematol 2006; 13: 67-73.
67. Camos M, Esteve J, Jares P, et al. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression. Cancer Res 2006; 66: 6947-54.
68. Faiella A, Zappavigna V, Mavilio F, Boncinelli E. Inhibition of retinoic acid-induced activation of 3′ human HOXB genes by antisense oligonucleotides affects sequential activation of genes located upstream in the four HOX clusters. Proc Natl Acad Sci U S A 1994; 91: 5335-9.
69. Kawagoe H, Kawagoe R, Sano K. Targeted down-regulation of MLL-AF9 with antisense oligodeoxyribonucleotide reduces the expression of the HOXA7 and -A10 genes and induces apoptosis in a human leukemia cell line THP-1. Leukemia 2001; 15: 1743-9.
70. Bruhl T, Urbich C, Aicher D, Acker-Palmer A, Zeiher AM, Dimmeler S. Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ Res 2004; 94: 743-51.
71. Lu PY, Xie F, Woodle MC. In vivo application of RNA interference: from functional genomics to therapeutics, Adv Genet 2005; 54: 117-42.
72. Schiffelers RM, Ansari A, Xu J, et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted. sterically stabilized nanoparticle. Nucleic Acids Res 2004; 32: 149.
73. Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res 2004; 64(10): 3365-70.
74. Wei J, Zhai L, Xu J, Wang H. Role of Bmil in H2A ubiquitylation and Hox gene silencing. J Biol Chem 2006; 281: 22537-44.
75. Li LC, Okino ST, Zhao H, et al. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA 2006; 103: 17337-42.